Call us toll free: +(9122) 4919 8700
For India Specific Distributed Products from leading companies worldwide, please visit our new website – www.krishgenbio.com
Call us toll free India No. +(9122) 4919 8700
USA No. (562)-568-5005 (562)-568-5006
ELISA wash buffer was developed as a high performance washing solution for use in all ELISA formats
Procedure for Determination of Percentage Difference in Reduction between treated and control cells in Cytotoxicity / Proliferation Assays
Please follow these instructions while you are using KRISHGEN BioSystems Cytokine Kits to get better results and avoid unwanted errors
Flowing Software is a research project of Cell Imaging Core, Turku Centre for Biotechnology.
FastPrep-Q / Plasmid SV/ XfectionSeries (Selection Guide)
to improve your pipetting technique of all the factors contributing to the performance of a pipette, the most critical are the skill and expertise of the operator.
LINEAR-LINEAR GRAPH PAPER ON A4 SIZE
We have compiled a list with 13 of the most common problems that researchers encounter when culturing primary cells.
Follow these simple rules to ensure healthy and reproducible cell cultures.
KRIBIOLISA Semaglutide-ELISA-Validation_Guide_2025
Krishgen’s 7 Point ELISA Validation System
Validation of Bevacizumab ELISA – ICH Q2
Validation Report of KBBA36 Endonuclease S.mascarens ELISA
Details of Factor IIa and Factor Xa Assay Kit
Validation Guide For Krishgen Mycoplasma
Validation of CHO HCP ELISA
Validation of KBH0321_Human Terminal Complement Complex C5b-9 ELISA version 1-0
Validation of Factor IIa Assay for Nadroparin Calcium-Nadroparin Injection
KRIBIOLISA Atezolizumab-ELISA-Validation_Guide_2025_ver 1.0
Validation Guide_Kribiolisa_Anti-Tenecteplase ELISA_KBI9062
Validation Guide_KRIBIOLISA Anti-Semaglutide ELISA(CATALOG NO KBI9030)
Validation_Guide_Human N-methyl-d-aspartic Acid NMDA GENLISA ELISA (CATALOG NO KBH1051) _ver1-0
Validation Guide_KRIBIOLISA Guselkumab (TREMFYA) ELISA
Validation Guide_KRIBIOLISA HEK HCP ELISA (CATALOG NO KBBP15)
KRIBIOLISA Anti-Liraglutide-ELISA-Validation_Guide 2025_ver 1.0
KRIBIOLISA Daratumumab-ELISA-Validation_Guide 2025_ver 1.0
KRIBIOLISA Eculizumab-ELISA-Validation_Guide 2025_ver 1.0
KRIBIOLISA Pembrolizumab-ELISA-Validation_Guide_2025
Validation_Guide_For_Krishgen_Mycoplasma_Detection_Kit_ver 3.0
GENLISA Human GLP-1-ELISA-Validation_Guide 2025_ver 1.0
KRIBIOLISA Alemtuzumab-ELISA-Validation_Guide 2025
KRIBIOLISA Anti-Aspart ELISA-Validation_Guide 2025_ver 1.0
KRIBIOLISA ds RNA J2-ELISA-Validation_Guide_2025_ver 1.0
KRIBIOLISA-Amivantamab-ELISA_Validation Guide_ver1-0
KRIBIOLISA-Bimagrumab-ELISA_Validation Guide_ver1-0
KRIBIOLISA-Certolizumab Pegol Inhibition-ELISA_Validation Guide_ver1-0
KRIBIOLISA Anti – Denosumab-ELISA_Validation Guide_ver1-0
KRIBIOLISA-Aducanumab-ELISA_Validation Guide_ver1-0
KRIBIOLISA-Anti- Obinutuzumab-ELISA_Validation Guide_ver1-0
KRIBIOLISA-Anti Ustekinumab-ELISA_Validation Guide_ver1-0
KRIBIOLISA-Blinatumomab-ELISA_Validation Guide_ver1-0
KRIBIOLISA-Burosumab-ELISA_Validation Guide_ver1-0
KRIBIOLISA-Evolocumab-ELISA_Validation Guide_ver1-0